Inflammation is a key and invariant pathological feature of the Alzheimer's disease (AD) brain, and the impact on disease progression and neurodegeneration remains an area of active investigation. In this Program Project we propose 5 Projects and 2 supporting Cores. Each Project investigates how inflammation drives brain pathology in AD and how select AD risk factor genes (identified in genome-wide association studies (GWAS)) contribute to the progression of inflammation-driven pathogenesis. The common mechanistic thread linking the Projects is the idea that inflammation and beta-amyloid (A?) impair endosomal trafficking and autophagy, which ultimately drives neuronal dysfunction, impaired synaptic plasticity, and deteriorating cognitive health. The team leading the projects has a long history of collaboration and major contributions to the AD field. Project 1: Intracellulr amyloid accumulation, innate immunity and pathogenesis. Charles Glabe, Project Leader. Project 1 proposes that the accumulation of intracellular A??contributes to pathogenesis by activating an innate inflammatory cascade that represents a futile attempt to degrade or eliminate A? via activation of autophagy. Project 2: Inflammation and A? Impair BDNF Signaling and the Regulation of Synaptic Plasticity, Carl Cotman, Project Leader. Project 2 proposes that inflammation and A? compromise synaptic plasticity and neuronal viability by impairing, endosomal trafficking and neurotrophic factor signaling, in particular BDNF-TrkB. Project 3: Linking A? and tau pathology through IL-1? signaling: relevance of changes in protein trafficking and clearance mechanisms for the disease progression. Frank LaFerIa, Project Leader. Project 3 proposes that a cascade exists by which A? species provoke inflammation, which subsequently drives tau pathology. Project 4: Neuroprotection vs. neuroinflammatlon induced by complement proteins and receptors. Andrea Tenner, Project Leader. Project 4 will define the molecular basis of C1q dependent neuroprotection and the functional consequences of CR1 gene polymorphisms, a risk factor for AD. Project 5: PICALM, oligomeric A? and inflammation in neurovascular pathogenesis in Alzheimer's disease, David Cribbs, Project Leader. Project 5 investigates how A? and inflammation affect cerebrovascular function, and incorporates AD risk factor genes that are linked to inflammation/endosomal processing.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Wise, Bradley C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
Internal Medicine/Medicine
Organized Research Units
United States
Zip Code
Rice, Rachel A; Berchtold, Nicole C; Cotman, Carl W et al. (2014) Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production. Neurobiol Aging 35:1002-11
Elmore, Monica R P; Najafi, Allison R; Koike, Maya A et al. (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380-97
Berchtold, Nicole C; Sabbagh, Marwan N; Beach, Thomas G et al. (2014) Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Neurobiol Aging 35:1961-72
Hatami, Asa; Albay 3rd, Ricardo; Monjazeb, Sanaz et al. (2014) Monoclonal antibodies against A?42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain. J Biol Chem 289:32131-43
Smith, Erica D; Prieto, G Aleph; Tong, Liqi et al. (2014) Rapamycin and interleukin-1? impair brain-derived neurotrophic factor-dependent neuron survival by modulating autophagy. J Biol Chem 289:20615-29
Pensalfini, Anna; Albay 3rd, Ricardo; Rasool, Suhail et al. (2014) Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis 71:53-61
Passos, Giselle F; Medeiros, Rodrigo; Cheng, David et al. (2013) The bradykinin B1 receptor regulates A? deposition and neuroinflammation in Tg-SwDI mice. Am J Pathol 182:1740-9
Medeiros, Rodrigo; LaFerla, Frank M (2013) Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239:133-8
Benoit, Marie E; Hernandez, Michael X; Dinh, Minhan L et al. (2013) C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-* neurotoxicity. J Biol Chem 288:654-65
Fonseca, Maria I; McGuire, Susan O; Counts, Scott E et al. (2013) Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology. J Neuroinflammation 10:25

Showing the most recent 10 out of 220 publications